185 related articles for article (PubMed ID: 30387874)
1. Food and drug administration's regulatory shift on direct-to-consumer genetic tests for cancer risk.
Yang YT; Zettler PJ
Cancer; 2019 Jan; 125(1):12-14. PubMed ID: 30387874
[No Abstract] [Full Text] [Related]
2. How Should Patients and Providers Interpret the US Food and Drug Administration's Regulatory Language for Direct-to-Consumer Genetic Tests?
Kilbride MK; Domchek SM; Bradbury AR
J Clin Oncol; 2019 Oct; 37(28):2514-2517. PubMed ID: 31173557
[No Abstract] [Full Text] [Related]
3. Direct-to-Consumer Genetic Testing: Finding a Clear Path Forward.
Seward B
Ther Innov Regul Sci; 2018 Jul; 52(4):482-488. PubMed ID: 29714553
[TBL] [Abstract][Full Text] [Related]
4. Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.
Gill J; Obley AJ; Prasad V
JAMA; 2018 Jun; 319(23):2377-2378. PubMed ID: 29800087
[No Abstract] [Full Text] [Related]
5. A review of the legislation of direct-to-consumer genetic testing in EU member states.
Hoxhaj I; Stojanovic J; Sassano M; Acampora A; Boccia S
Eur J Med Genet; 2020 Apr; 63(4):103841. PubMed ID: 31923586
[No Abstract] [Full Text] [Related]
6. Directed to consumer genetic testing. Perspective from the Ethics commission of the Spanish Society for Human Genetics.
Pàmpols Ros T; García Sagredo JM; Pérez Aytés A; Díaz de Bustamante A
Med Clin (Barc); 2019 Jul; 153(1):35-40. PubMed ID: 30898448
[No Abstract] [Full Text] [Related]
7. Direct-to-Consumer Medical Testing in the Era of Value-Based Care.
Rockwell KL
JAMA; 2017 Jun; 317(24):2485-2486. PubMed ID: 28542699
[No Abstract] [Full Text] [Related]
8. Direct-to-Consumer Genetic Testing and Potential Loopholes in Protecting Consumer Privacy and Nondiscrimination.
Hendricks-Sturrup RM; Prince AER; Lu CY
JAMA; 2019 May; 321(19):1869-1870. PubMed ID: 30998825
[No Abstract] [Full Text] [Related]
9. Direct-to-consumer Genetic Testing: Changes in the EU Regulatory Landscape.
Slokenberga S
Eur J Health Law; 2015 Dec; 22(5):463-80. PubMed ID: 26665691
[TBL] [Abstract][Full Text] [Related]
10. Patients Armed With Their Own Genetic Data Raise Tough Questions.
Storrs C
Health Aff (Millwood); 2018 May; 37(5):690-693. PubMed ID: 29733706
[TBL] [Abstract][Full Text] [Related]
11. [Direct-to-consumer genetic testing: a regulation by the market, or a medical regulation?].
Jautrou H
Med Sci (Paris); 2020 Feb; 36(2):153-159. PubMed ID: 32129752
[TBL] [Abstract][Full Text] [Related]
12. The Future of DTC Genomics and the Law.
Greely HT
J Law Med Ethics; 2020 Mar; 48(1):151-160. PubMed ID: 32342782
[TBL] [Abstract][Full Text] [Related]
13. New EU Rules for In Vitro Diagnostic Genetic Tests, a First Step in the Right Direction.
Roscam Abbing HDC
Eur J Health Law; 2017 Apr; 24(2):121-33. PubMed ID: 29210257
[No Abstract] [Full Text] [Related]
14. Don’t Try This at Home: the FDA’s Restrictive Regulation of Home Testing Devices.
Baird S
Duke Law J; 2017 Nov; 67(2):383-426. PubMed ID: 29469551
[TBL] [Abstract][Full Text] [Related]
15. Direct-To-Consumer Genetic Testing: Is the Public Ready for Simple, At-Home DNA Tests to Detect Disease Risk?
Bates M
IEEE Pulse; 2018; 9(6):11-14. PubMed ID: 30452341
[TBL] [Abstract][Full Text] [Related]
16. Direct-to-consumer misleading information on cancer risks calls for an urgent clarification of health genetic testing performed by commercial companies.
de Pauw A; Schwartz M; Colas C; Golmard L; Stoppa-Lyonnet D
Eur J Cancer; 2020 Jun; 132():100-103. PubMed ID: 32335476
[TBL] [Abstract][Full Text] [Related]
17. Direct-to-Consumer Genetic Testing and Orphan Drug Development.
Mason M; Levenson J; Quillin J
Genet Test Mol Biomarkers; 2017 Aug; 21(8):456-463. PubMed ID: 28696792
[TBL] [Abstract][Full Text] [Related]
18. [Advantages and disadvantages of direct-to-consumer genetic tests].
Christiansen CW; Gerdes AA
Ugeskr Laeger; 2017 Mar; 179(11):. PubMed ID: 28330535
[TBL] [Abstract][Full Text] [Related]
19. 23andMe Paves the Way for Direct-to-Consumer Genetic Health Risk Tests of Limited Clinical Utility.
Wynn J; Chung WK
Ann Intern Med; 2017 Jul; 167(2):125-126. PubMed ID: 28554190
[No Abstract] [Full Text] [Related]
20. “Better Not to Know?”: Justifiable Limits on the Right to Information in the Realm of DTC Genetic Testing. An Analysis of the European and Spanish Legal Framework.
Martínez Otero JM
Eur J Health Law; 2017 Apr; 24(2):175-97. PubMed ID: 29210260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
